1-(2,4-Dibromophenyl)-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one: A Novel Opioid Receptor Agonist with Less Accompanying Gastrointestinal Dysfunction than Morphine.
2017
Background:The authors investigated the pharmacology and signaling pathways of the opioid receptors modulated by compound 1, 1-(2,4-dibromophenyl)-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one.Methods:In vitro studies of compound 1 were assessed by using a radioligand-binding assay (n = 3), a
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
48
References
5
Citations
NaN
KQI